Evista and Deltasone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Evista (raloxifene hydrochloride) and Deltasone (prednisone). Common drug interactions include anxiety among females.

The phase IV clinical study analyzes what interactions people have when they take Evista and Deltasone. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Evista?

Evista has active ingredients of raloxifene hydrochloride. It is often used in osteoporosis. eHealthMe is studying from 25,891 Evista users. Check the latest studies of Evista.

What is Deltasone?

Deltasone has active ingredients of prednisone. eHealthMe is studying from 4,243 Deltasone users. Check the latest studies of Deltasone.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 17, 2026

20 people who take Evista and Deltasone together, and have interactions are studied.

What are the common drug interactions of Evista and Deltasone, by gender? *:

female:

Anxiety
Depression
Appendicitis (inflammation of the appendix)
Asthma
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Decreased appetite
Dyspnoea exertional (breathlessness or shortness of breath)
Hyperlipidaemia (presence of excess lipids in the blood)
Hypoacusis (loss of hearing)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)

male:

n/a

What are the common drug interactions of Evista and Deltasone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Hypertension (high blood pressure)
Anxiety
Appendicitis (inflammation of the appendix)
Asthma
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Depression
Dyspnoea exertional (breathlessness or shortness of breath)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hyperlipidaemia (presence of excess lipids in the blood)
Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)

60+:

Genitourinary tract infection (infection of genital tract and urinary tract)
Hypernatraemia (an abnormally high plasma concentration of sodium ions)
Cough
Drug hypersensitivity
Dysgeusia (disorder of the sense of taste)
Dyspnoea (difficult or laboured respiration)
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
Weight decreased
Abdominal pain upper
Acinetobacter infection (infection by group of bacteria commonly found in soil and water)

What are the existing conditions these people have? *

Abdominal Discomfort: 3 people, 15.00%
Depression: 3 people, 15.00%
Arteritis (inflammation of the walls of arteries): 3 people, 15.00%
Asthma: 3 people, 15.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 15.00%
Constipation: 3 people, 15.00%
Stress And Anxiety: 2 people, 10.00%
Oedema (fluid collection in tissue): 2 people, 10.00%
Nausea (feeling of having an urge to vomit): 2 people, 10.00%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Evista and Deltasone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously